Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
01/2003
01/09/2003CA2452105A1 Dibenzocycloheptene compound
01/09/2003CA2452082A1 Extracellular messengers
01/09/2003CA2452030A1 Sustained release pharmaceutical composition
01/09/2003CA2451955A1 Antibodies to opgl
01/09/2003CA2451816A1 Intradermal delivery of vaccines and gene therapeutic agents via microcannula
01/09/2003CA2451770A1 Method and apparatus for computer modeling of an adaptive immune response
01/09/2003CA2451739A1 Hcv e1e2 vaccine compositions
01/09/2003CA2451711A1 Immunopotentiator for mammary gland of dairy cows containing lactoferrin as an active ingredient
01/09/2003CA2451464A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
01/09/2003CA2451236A1 Peptides for use as translocation factors
01/09/2003CA2451128A1 N-heterocyclic inhibitors of tnf-alpha expression
01/09/2003CA2451125A1 N-heterocyclic inhibitors of tnf-alpha expression
01/09/2003CA2450722A1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
01/09/2003CA2450686A1 Substituted 8-arylquinoline pde4 inhibitors
01/09/2003CA2424645A1 New use of dipeptidyl peptidase iv inhibitors
01/09/2003CA2418543A1 New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
01/08/2003EP1273580A1 Sulfonyl heteroaryl triazoles as anti-inflammatory and analgesic agents
01/08/2003EP1273578A1 Benzopyran derivatives and antiallergic agent containing the same
01/08/2003EP1273576A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents
01/08/2003EP1273305A1 Medical preparation for inhalation comprising Antithrombin for treating inflammatory lung diseases and ARDS
01/08/2003EP1273297A1 Vitamin E for the treatment of diseases in which the binding of the transcription factor NF-KB and/or AP-1 to promoter target sites has a beneficial effect (eg AIDS, cardiac infarction)
01/08/2003EP1273289A1 Pharmaceutical compositions containing ascomycin derivatives
01/08/2003EP1273288A1 Pharmaceutical compositions containing rapamycin derivatives
01/08/2003EP1272638A2 Drug metabolizing enzymes
01/08/2003EP1272637A1 A METHOD FOR SCREENING FOR AUTOIMMUNE DISEASE BY IDENTIFYING POLYMORPHISMS IN IL-12 p40
01/08/2003EP1272633A2 Compositions and methods for dendritic cell-based immunotherapy
01/08/2003EP1272614A1 Differentiation of bone marrow cells into neuronal cells and uses therefor
01/08/2003EP1272527A2 Anti-d monoclonal antibodies
01/08/2003EP1272526A1 Enhancement of antibody-mediated immune responses
01/08/2003EP1272518A2 Cd20/ige-receptor like molecules and uses thereof
01/08/2003EP1272515A2 Immunoregulator
01/08/2003EP1272511A2 Molecules associated with human reproduction
01/08/2003EP1272505A1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
01/08/2003EP1272504A1 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
01/08/2003EP1272488A2 Tri-aryl-substituted-ethane pde4 inhibitors
01/08/2003EP1272487A1 Bicyclic heteroaryl compounds as inhibitors of the interaction between the integrin alpha4beta1 receptor and vcam-1 and/or fibronectin
01/08/2003EP1272484A2 Benzoamide piperidine compounds as substance p antagonists
01/08/2003EP1272455A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
01/08/2003EP1272225A2 Lipid-based systems for targeting diagnostic agents
01/08/2003EP1272223A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same
01/08/2003EP1272222A2 Compositions for drug delivery
01/08/2003EP1272221A2 Peptide conjugates for drug delivery
01/08/2003EP1272215A2 Pharmaceutical preparations comprising modified peptides
01/08/2003EP1272214A1 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
01/08/2003EP1272213A2 Microbial delivery system
01/08/2003EP1272205A1 Sialoadhesin factor-2 antibodies
01/08/2003EP1272201A2 Use of compatible solutes as substances having free radical scavenging properties
01/08/2003EP1272200A1 Divided dose therapies with vascular damaging activity
01/08/2003EP1272186A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
01/08/2003EP1272185A2 Use of quinazoline derivatives as angiogenesis inhibitors
01/08/2003EP1272175A2 Il-8 receptor antagonists
01/08/2003EP1272169A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
01/08/2003EP1272163A2 Pharmaceutical compositions
01/08/2003EP1272161A2 Lipid-based drug delivery systems against parasitic infections
01/08/2003EP1272160A2 Lipid-based drug delivery systems for topical application
01/08/2003EP1123276B1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
01/08/2003EP1023266B1 Process for making diaryl pyridines useful as cox-2 inhibitors
01/08/2003EP0981375B1 Pharmaceutical compositions containing plasma protein
01/08/2003EP0892795B1 Piperidinylpyramidine derivatives
01/08/2003EP0859622B1 Extracts of shark cartilage
01/08/2003EP0833649B1 Methods of preventing or treating allergies
01/08/2003EP0817646B1 Methods of treating inflammation and compositions therefor
01/08/2003EP0607309B1 The regulation of systemic immune responses utilizing cytokines and antigens
01/08/2003CN1390257A Transfer compounds, the production and the use thereof
01/08/2003CN1390256A Novel protein and DNA thereof
01/08/2003CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors
01/08/2003CN1390220A Kinase inhibitors as therapeutic agents
01/08/2003CN1390219A Pyrazolopyrimidines as therapeutic agents
01/08/2003CN1390215A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor
01/08/2003CN1390207A [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinyl amino] acetamide derivatives, process for producing the same, medicinal compositions the same and intermediate of these compounds
01/08/2003CN1390138A Novel use of antibodies as vaccines
01/08/2003CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders
01/08/2003CN1390136A Vaccine against nepatitis B virus and human papilloma virus
01/08/2003CN1390129A Solutions containing epinastine
01/08/2003CN1390122A Tissue factor antagonists and methods of use thereof
01/08/2003CN1389475A Wolfberry polysaccharide and its prepn. and application
01/08/2003CN1389265A Composite Chinese medicine with health care function
01/08/2003CN1389214A Compound liniment for treating autoimmune disease
01/08/2003CN1098266C Fused pyrrolo (2,3-c) carbazole-6-one which potentiate activity of gamma interferon
01/08/2003CN1098264C Substituted 4-(1H-benzimidzol-2-yl-amino) piepridines useful for the treatment of allergic diseases
01/08/2003CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
01/08/2003CN1098255C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity
01/07/2003US6504020 Isolated nucleic acids comprising Listeria dal and dat genes
01/07/2003US6504013 Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
01/07/2003US6504005 Long-acting drugs and pharmaceutical compositions comprising them
01/07/2003US6503930 Pyrazole derivatives as p38 kinase inhibitors
01/07/2003US6503926 Nitrogen heterocycle compounds
01/07/2003US6503914 Thienopyrimidine-based inhibitors of the Src family
01/07/2003US6503908 Pharmaceutically active compounds
01/07/2003US6503905 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
01/07/2003US6503882 Treatment of HIV
01/07/2003US6503737 Isolated nucleic acids relating to the fkbA gene within the FK-520 polyketide synthase gene cluster
01/07/2003US6503713 Methods for identifying RNA binding compounds
01/07/2003US6503542 Herbal compositions for treating immunological disorders
01/07/2003US6503513 Diagnostics and therapy of diseases associated with HHV-8 infections
01/07/2003US6503512 Anti-AIDS immunomodulator complex
01/07/2003US6503511 Derivatives of choline binding proteins for vaccines
01/07/2003US6503509 Method for receptor desensitization
01/07/2003US6503506 Nutrient therapy for immuno-compromised patients
01/07/2003US6503505 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799).